• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清中舒林酸及其代谢物的液相色谱测定法。

Liquid chromatographic determination of sulindac and metabolites in serum.

作者信息

Clark C R, McMillian C L, Hoke J F, Campagna K D, Ravis W R

出版信息

J Chromatogr Sci. 1987 Jun;25(6):247-51. doi: 10.1093/chromsci/25.6.247.

DOI:10.1093/chromsci/25.6.247
PMID:3611280
Abstract

An improved liquid chromatographic procedure is described for the quantitative determination of sulindac, sulindac sulfone, and sulindac sulfide from serum. The procedure makes use of acetonitrile extraction of the compounds of interest from acidified serum samples. Under these conditions extraction efficiencies in the 85 percent range are obtained for each of the compounds. The liquid chromatographic separation of the compounds of interest and the internal standard (indomethacin) is accomplished in an isocratic elution procedure using a nitrile (CN) stationary phase. The HPLC separation procedure is completed in less than 10 minutes, giving excellent resolution and peak shape.

摘要

本文描述了一种改进的液相色谱法,用于定量测定血清中的舒林酸、舒林酸砜和舒林酸硫化物。该方法利用乙腈从酸化的血清样品中萃取目标化合物。在这些条件下,每种化合物的萃取效率在85%左右。目标化合物和内标(吲哚美辛)的液相色谱分离是在等度洗脱过程中使用腈基(CN)固定相完成的。高效液相色谱分离过程在不到10分钟内完成,具有出色的分离度和峰形。

相似文献

1
Liquid chromatographic determination of sulindac and metabolites in serum.血清中舒林酸及其代谢物的液相色谱测定法。
J Chromatogr Sci. 1987 Jun;25(6):247-51. doi: 10.1093/chromsci/25.6.247.
2
Analysis of sulindac and metabolites in plasma and urine by high-performance liquid chromatography.采用高效液相色谱法分析血浆和尿液中的舒林酸及其代谢产物。
J Chromatogr. 1987 Jan 23;413:171-80. doi: 10.1016/0378-4347(87)80224-4.
3
Measurement of sulindac and its metabolites in human plasma and urine by high-performance liquid chromatography.采用高效液相色谱法测定人血浆和尿液中舒林酸及其代谢物。
J Chromatogr. 1981 Sep 11;225(1):123-30. doi: 10.1016/s0378-4347(00)80251-0.
4
Determination of sulindac and its metabolites in serum by high-performance liquid chromatography.高效液相色谱法测定血清中舒林酸及其代谢产物
J Chromatogr. 1979 Apr 1;171:490-3. doi: 10.1016/s0021-9673(01)95342-7.
5
Biotransformation of sulindac in end-stage renal disease.
Clin Pharmacol Ther. 1987 Jul;42(1):82-8. doi: 10.1038/clpt.1987.112.
6
Analytical methods for the determination of sulindac and metabolites in plasma, urine, bile, and gastric fluid by liquid chromatography using ultraviolet detection.采用液相色谱-紫外检测法测定血浆、尿液、胆汁和胃液中舒林酸及其代谢物的分析方法。
J Pharm Sci. 1984 Sep;73(9):1270-3. doi: 10.1002/jps.2600730921.
7
Determination of sulindac and its metabolites in human serum by reversed-phase high-performance liquid chromatography using on-line post-column ultraviolet irradiation and fluorescence detection.采用在线柱后紫外照射和荧光检测的反相高效液相色谱法测定人血清中的舒林酸及其代谢物。
J Chromatogr B Biomed Appl. 1995 Nov 3;673(1):91-6. doi: 10.1016/0378-4347(95)00239-f.
8
High-performance liquid chromatography of sulindac and its sulphone and sulphide metabolites in plasma.血浆中舒林酸及其砜和硫化物代谢物的高效液相色谱法
J Chromatogr. 1987 Feb 20;414(1):211-6. doi: 10.1016/0378-4347(87)80043-9.
9
[Thin layer and densitometry for quantitative determination of drugs. I. Identification and determination of sulindac and its metabolites in plasma].[用于药物定量测定的薄层色谱法和光密度测定法。I. 舒林酸及其代谢物在血浆中的鉴定与测定]
Boll Chim Farm. 1983 May;122(5):229-36.
10
Pharmacokinetics of graded oral doses of sulindac in man.
Arzneimittelforschung. 1984;34(2):226-9.

引用本文的文献

1
Effect of Sulindac Binary System on In Vitro and In Vivo Release Profiles: An Assessment of Polymer Type and Its Ratio.舒林酸二元体系对体外和体内释放曲线的影响:聚合物类型及其比例的评估
Biomed Res Int. 2016;2016:3182358. doi: 10.1155/2016/3182358. Epub 2016 Oct 20.
2
Formulation and Characterization of Solid Dispersion Prepared by Hot Melt Mixing: A Fast Screening Approach for Polymer Selection.热熔混合法制备固体分散体的处方设计与表征:聚合物选择的快速筛选方法
J Pharm (Cairo). 2014;2014:105382. doi: 10.1155/2014/105382. Epub 2014 Mar 12.
3
Comparative bioavailability of sulindac in capsule and tablet formulations.
舒林酸胶囊和片剂剂型的相对生物利用度。
Cancer Epidemiol Biomarkers Prev. 2008 Mar;17(3):674-9. doi: 10.1158/1055-9965.EPI-07-2510.
4
Polyamines reverse non-steroidal anti-inflammatory drug-induced toxicity in human colorectal cancer cells.多胺可逆转非甾体抗炎药对人结肠癌细胞的毒性作用。
Biochem J. 2003 Sep 1;374(Pt 2):481-8. doi: 10.1042/BJ20030280.
5
Clinical pharmacokinetics of sulindac. A dynamic old drug.舒林酸的临床药代动力学。一种有活力的老药。
Clin Pharmacokinet. 1997 Jun;32(6):437-59. doi: 10.2165/00003088-199732060-00002.
6
Comparison of susceptibility of inbred and outbred infant mice to Escherichia coli heat-stable enterotoxin STa.近交系和远交系幼鼠对大肠杆菌热稳定肠毒素STa敏感性的比较。
Infect Immun. 1992 Aug;60(8):3117-21. doi: 10.1128/iai.60.8.3117-3121.1992.